Shares of ConforMIS Inc. (NASDAQ:CFMS) saw an uptick in trading volume on Friday . 418,091 shares changed hands during mid-day trading, an increase of 41% from the previous session’s volume of 295,909 shares.The stock last traded at $9.68 and had previously closed at $8.61.

A number of brokerages have recently commented on CFMS. JPMorgan Chase & Co. decreased their price objective on shares of ConforMIS from $11.00 to $8.00 and set a “neutral” rating for the company in a research report on Tuesday, August 9th. Zacks Investment Research raised shares of ConforMIS from a “sell” rating to a “hold” rating in a research report on Friday, July 1st. B. Riley began coverage on shares of ConforMIS in a research report on Thursday. They issued a “buy” rating and a $13.00 price objective for the company. Finally, Oppenheimer Holdings Inc. lifted their price objective on shares of ConforMIS from $12.00 to $13.00 and gave the company an “outperform” rating in a research report on Tuesday, August 9th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $15.00.

The company’s market capitalization is $407.37 million. The stock has a 50 day moving average price of $7.92 and a 200-day moving average price of $8.84.

ConforMIS (NASDAQ:CFMS) last released its quarterly earnings data on Monday, August 8th. The company reported ($0.34) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.35) by $0.01. ConforMIS had a negative net margin of 84.33% and a negative return on equity of 45.30%. The firm had revenue of $19.30 million for the quarter, compared to the consensus estimate of $18.02 million. During the same quarter in the prior year, the company posted ($2.51) earnings per share. The business’s revenue was up .5% on a year-over-year basis. On average, equities analysts forecast that ConforMIS Inc. will post ($1.40) earnings per share for the current year.

In other ConforMIS news, insider Daniel Steines sold 30,000 shares of the company’s stock in a transaction on Friday, September 16th. The shares were sold at an average price of $9.09, for a total transaction of $272,700.00. Following the transaction, the insider now owns 245,213 shares in the company, valued at $2,228,986.17. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Kenneth P. Fallon III sold 4,000 shares of the company’s stock in a transaction on Wednesday, August 17th. The stock was sold at an average price of $8.44, for a total transaction of $33,760.00. Following the transaction, the director now owns 92,222 shares in the company, valued at approximately $778,353.68. The disclosure for this sale can be found here. Company insiders own 9.20% of the company’s stock.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Franklin Resources Inc. increased its position in ConforMIS by 28.7% in the first quarter. Franklin Resources Inc. now owns 726,700 shares of the company’s stock valued at $7,813,000 after buying an additional 162,100 shares during the last quarter. BlackRock Institutional Trust Company N.A. increased its position in ConforMIS by 0.9% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 272,339 shares of the company’s stock valued at $2,928,000 after buying an additional 2,347 shares during the last quarter. Royce & Associates LP increased its position in ConforMIS by 148.8% in the first quarter. Royce & Associates LP now owns 180,600 shares of the company’s stock valued at $1,941,000 after buying an additional 108,000 shares during the last quarter. Geode Capital Management LLC increased its position in ConforMIS by 15.1% in the first quarter. Geode Capital Management LLC now owns 77,877 shares of the company’s stock valued at $837,000 after buying an additional 10,235 shares during the last quarter. Finally, Wellington Management Group LLP increased its position in ConforMIS by 58.1% in the first quarter. Wellington Management Group LLP now owns 5,187,018 shares of the company’s stock valued at $55,760,000 after buying an additional 1,905,943 shares during the last quarter. Hedge funds and other institutional investors own 41.38% of the company’s stock.

About ConforMIS

ConforMIS, Inc is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee.

5 Day Chart for NASDAQ:CFMS

Receive News & Ratings for ConforMIS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConforMIS Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.